Maccura Biotechnology Co.Ltd (300463.SZ)
CNY 11.88
(-0.42%)
CNY 11.88
(-0.42%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 907.48 Million CNY | -12.7% |
| 2022 | 1.03 Billion CNY | -3.43% |
| 2021 | 1.07 Billion CNY | 0.15% |
| 2020 | 1.07 Billion CNY | 26.2% |
| 2019 | 851.67 Million CNY | 16.49% |
| 2018 | 731.11 Million CNY | 33.38% |
| 2017 | 548.12 Million CNY | 52.56% |
| 2016 | 359.29 Million CNY | 34.63% |
| 2015 | 266.87 Million CNY | 39.46% |
| 2014 | 191.35 Million CNY | 10.48% |
| 2013 | 173.2 Million CNY | 28.61% |
| 2012 | 134.67 Million CNY | 42.46% |
| 2011 | 94.53 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 1 Billion CNY | 11.27% |
| 2024 Q3 | 1 Billion CNY | 1.19% |
| 2024 Q2 | 990.96 Million CNY | -1.87% |
| 2023 Q4 | 907.48 Million CNY | -16.93% |
| 2023 Q3 | 1.09 Billion CNY | 0.98% |
| 2023 Q1 | 1.12 Billion CNY | 8.3% |
| 2023 FY | 907.48 Million CNY | -12.7% |
| 2023 Q2 | 1.08 Billion CNY | -3.9% |
| 2022 Q4 | 1.03 Billion CNY | 3.8% |
| 2022 Q3 | 1 Billion CNY | 0.58% |
| 2022 Q2 | 995.63 Million CNY | -2.3% |
| 2022 FY | 1.03 Billion CNY | -3.43% |
| 2022 Q1 | 1.01 Billion CNY | -5.33% |
| 2021 FY | 1.07 Billion CNY | 0.15% |
| 2021 Q4 | 1.07 Billion CNY | -4.72% |
| 2021 Q1 | 1.12 Billion CNY | 5.07% |
| 2021 Q2 | 1.1 Billion CNY | -2.38% |
| 2021 Q3 | 1.12 Billion CNY | 2.48% |
| 2020 Q4 | 1.07 Billion CNY | -6.13% |
| 2020 FY | 1.07 Billion CNY | 26.2% |
| 2020 Q2 | 1.13 Billion CNY | 19.75% |
| 2020 Q1 | 950.6 Million CNY | 11.62% |
| 2020 Q3 | 1.14 Billion CNY | 0.58% |
| 2019 Q4 | 851.67 Million CNY | -3.57% |
| 2019 Q3 | 883.24 Million CNY | 10.65% |
| 2019 Q2 | 798.26 Million CNY | 5.8% |
| 2019 Q1 | 754.53 Million CNY | 3.2% |
| 2019 FY | 851.67 Million CNY | 16.49% |
| 2018 FY | 731.11 Million CNY | 33.38% |
| 2018 Q2 | 619.92 Million CNY | -5.28% |
| 2018 Q1 | 654.48 Million CNY | 19.4% |
| 2018 Q4 | 731.11 Million CNY | 5.12% |
| 2018 Q3 | 695.52 Million CNY | 12.19% |
| 2017 Q1 | 381.84 Million CNY | 6.28% |
| 2017 FY | 548.12 Million CNY | 52.56% |
| 2017 Q4 | 548.12 Million CNY | 8.18% |
| 2017 Q3 | 506.66 Million CNY | 23.95% |
| 2017 Q2 | 408.76 Million CNY | 7.05% |
| 2016 FY | 359.29 Million CNY | 34.63% |
| 2016 Q4 | 359.29 Million CNY | -0.96% |
| 2016 Q3 | 362.76 Million CNY | 4.95% |
| 2016 Q2 | 345.67 Million CNY | 7.07% |
| 2016 Q1 | 322.83 Million CNY | 20.97% |
| 2015 Q1 | 225.97 Million CNY | 18.09% |
| 2015 FY | 266.87 Million CNY | 39.46% |
| 2015 Q4 | 266.87 Million CNY | 2.71% |
| 2015 Q3 | 259.83 Million CNY | 27.75% |
| 2015 Q2 | 203.39 Million CNY | -9.99% |
| 2014 FY | 191.35 Million CNY | 10.48% |
| 2014 Q4 | 191.35 Million CNY | 0.0% |
| 2014 Q1 | - CNY | 0.0% |
| 2013 FY | 173.2 Million CNY | 28.61% |
| 2012 FY | 134.67 Million CNY | 42.46% |
| 2011 FY | 94.53 Million CNY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Dian Diagnostics Group Co.,Ltd. | 1.5 Billion CNY | 39.86% |
| Hangzhou Tigermed Consulting Co., Ltd. | 23.39 Million CNY | -3778.543% |
| Dirui Industrial Co.,Ltd. | 572.93 Million CNY | -58.393% |
| Beijing Strong Biotechnologies, Inc. | 229.74 Million CNY | -294.999% |
| Medicalsystem Biotechnology Co., Ltd. | 259.01 Million CNY | -250.368% |
| Guangzhou Wondfo Biotech Co.,Ltd | 351.4 Million CNY | -158.249% |
| Guangdong Hybribio Biotech Co.,Ltd. | 99.55 Million CNY | -811.518% |
| BGI Genomics Co., Ltd. | 602.18 Million CNY | -50.7% |
| Amoy Diagnostics Co., Ltd. | 28.78 Million CNY | -3052.901% |
| Shanghai Labway Clinical Laboratory Co., Ltd. | 367.71 Million CNY | -146.795% |